Elicit vs ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM
Elicit vs ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM, compared side by side on 9 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Elicit is on 62/100 and ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM on 42/100.
Where each one leads
Elicit
- our overall score: 62/100 against 42/100
ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM
- funding raised: $39.6M against $31.0M
At a glance
| Measure | Elicit | ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM |
|---|---|---|
| What it is | AI-powered research assistant for scientific literature review and data extraction. | A consortium focused on incubating and developing technology in the medtech and pharma sectors in Israel. |
| Category | Artificial Intelligence, Biotechnology, Pharmaceuticals, Research & Development | MedTech, Pharma, Biotechnology, Incubator |
| Sells toBusiness model | B2B | Not published |
| Offering | Software | Services |
| Founded | 2021 | Not published |
| Headquarters | Oakland, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Elicit | ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM |
|---|---|---|
| Employees | 52 | Not published |
| Headcount growthLast 12 months | -36.8% | Not published |
| Total funding | $31.0M | $39.6M |
| Latest round | Series A | Not published |
| Valuation | $100M | Not published |
| LinkedIn followers | 8,026 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Elicit | ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 42/100 |
| Traction | 55/100 | 13/100 |
| Team | 60/100 | Not published |
| Search visibility | 51/100 | Not published |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (35/100) | Not published |
| Domain ratingLink authority, 0-100 | 75/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Elicit | ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Framer | Not detected |
| Support stack | Intercom | Not detected |
| Open source | Yes | No |
Elicit vs ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM: common questions
Which is better, Elicit or ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM?
On our 0-100 score Elicit rates higher (62/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 9 data points above: read the rows that match what you are buying for.
How do Elicit and ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM compare on the numbers?
Elicit leads on our overall score (62/100 against 42/100). ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM leads on funding raised ($39.6M against $31.0M).
Read the full Elicit review and pricing or the ISRAEL VENTURES PLUS INCUBATORS TEC MEDITECH PHARMA CONSORTIUM review and pricing. You can also browse other Elicit alternatives we track.